Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Medicines information provided by pharmaceutical representatives: a comparative study in Australia and Malaysia.

Othman N, Vitry AI, Roughead EE, Ismail SB, Omar K.

BMC Public Health. 2010 Nov 30;10:743. doi: 10.1186/1471-2458-10-743.

2.
4.

Doctors' opinions of information provided by Libyan pharmaceutical company representatives.

Alssageer MA, Kowalski SR.

Libyan J Med. 2012;7. doi: 10.3402/ljm.v7i0.19708. Epub 2012 Nov 28.

5.
6.
7.
8.

Attitudes of general practitioners in New Zealand to pharmaceutical representatives.

Thomson AN, Craig BJ, Barham PM.

Br J Gen Pract. 1994 May;44(382):220-3.

10.

A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the northern state of Malaysia.

Chua GN, Hassali MA, Shafie AA, Awaisu A.

Health Policy. 2010 May;95(2-3):229-35. doi: 10.1016/j.healthpol.2009.11.019. Epub 2009 Dec 30.

PMID:
20044165
11.

[Cooperation between physicians and pharmaceutical consultants. A questionnaire study].

Husby T.

Tidsskr Nor Laegeforen. 1991 Sep 20;111(22):2758-60. Norwegian.

PMID:
1948870
12.

Patient awareness and concern regarding pharmaceutical manufacturer interactions with doctors.

Edwards D, Ballantyne A.

Intern Med J. 2009 Mar;39(3):191-6. doi: 10.1111/j.1445-5994.2008.01887.x.

PMID:
19383067
13.

Naturopaths practice behaviour: provision and access to information on complementary and alternative medicines.

Smith C, Martin K, Hotham E, Semple S, Bloustien G, Rao D.

BMC Complement Altern Med. 2005 Jul 11;5:15.

14.
15.

Pharmacist, general practitioner and consumer use of written medicine information in Australia: are they on the same page?

Hamrosi KK, Raynor DK, Aslani P.

Res Social Adm Pharm. 2014 Jul-Aug;10(4):656-68. doi: 10.1016/j.sapharm.2013.10.002. Epub 2013 Oct 12.

PMID:
24239213
16.

General beliefs about medicines among doctors and nurses in out-patient care: a cross-sectional study.

MĂ„rdby AC, Akerlind I, Hedenrud T.

BMC Fam Pract. 2009 May 18;10:35. doi: 10.1186/1471-2296-10-35.

17.

[Early achievements of the Danish pharmaceutical industry--8. Lundbeck].

Grevsen JV, Kirkegaard H, Kruse E, Kruse PR.

Theriaca. 2016;(43):9-61. Danish.

PMID:
27491172
18.

[Quality of pharma rep meetings in general practice].

Straand J, Christensen IJ.

Tidsskr Nor Laegeforen. 2008 Feb 28;128(5):555-7. Norwegian.

19.

The Pharmaceutical Benefits Scheme and implications for paediatric prescribing.

Sinha Y, Brien JA, Craig JC.

J Paediatr Child Health. 2009 Jun;45(6):351-7. doi: 10.1111/j.1440-1754.2009.01500.x. Epub 2009 May 28.

PMID:
19490409
20.

Pharmaceutical sales representatives and patient safety: a comparative prospective study of information quality in Canada, France and the United States.

Mintzes B, Lexchin J, Sutherland JM, Beaulieu MD, Wilkes MS, Durrieu G, Reynolds E.

J Gen Intern Med. 2013 Oct;28(10):1368-75. doi: 10.1007/s11606-013-2411-7. Epub 2013 Apr 5.

Supplemental Content

Support Center